Inceptua Strengthening Presence in China

Inceptua Strengthening Presence in China

Inceptua’s presence in China is being strengthened as we continue to grow in line with the demand for Clinical Trial Supply and associated Services in the country, the largest in the world with a population that now exceeds 1.4bn.

China is now the second-largest pharmaceutical market in the world, and with a more harmonized and efficient clinical trial approval process, it is seeing a large increase in clinical trial activity.

Clinical Trial Supply in China

As we are strengthening our presence and offering of Clinical Trial Supply in China, we are delighted to present Ryan Zhang as Regional Director Business Development and a member of Inceptua’s growing China team. Ryan is based in Shanghai and brings significant experience to the Inceptua family. 

A native of Shanghai, Ryan obtained a bachelor’s degree in finance from Tongji University and began his career at DHL where he supported national and international demand. He moved on to hold positions with HSBC, World Courier and most recently Shanghai Shengsheng Logistics where he set up and developed the international business division.

Over the years Ryan has developed a wealth of expertise in logistics and import / export, specializing in the Pharmaceutical and Biotechnology space. Having held leadership roles for several years now he joins Inceptua with the clear remit of supporting our clients within China to access clinical trial services and material sourcing outside of China, as well as multi-national companies than need our support for Clinical Trial Supply in China.


If you would like to contact Ryan directly to inquire about Inceptua’s support in China, or for Chinese companies requiring our support anywhere outside of China, this can be done via email:

Get more information about our Clinical Trial Supply services here.

During 2020/2021 we co-presented on the challenges and pitfalls of working in China with Pfizer: Click here to access the webinar on demand:


Latest News and Insights